Prothena Corporation plc

NASDAQ:PRTA

6.44

+0.12 (+1.82%)

4:07:29 PM EDT: $6.40 -0.04 (-0.54%)

Market Cap (Intraday)	352.68M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$6.95 Million
Adjusted EPS	-$1.22

See more estimates

10-Day MA	N/A
50-Day MA	N/A
200-Day MA	N/A

See more pivots

Prothena Corporation plc Stock, NASDAQ:PRTA

77 Sir John Rogersons Quay, Grand Canal Docklands, Dublin, Dublin 2

Ireland

Phone: +353.1.236.2500

Number of Employees: 163

http://www.prothena.com

Description

Prothena Corp. Plc is a clinical-stage neuroscience company, which engages in the discovery and development of novel therapies to change the course of devastating diseases. The firmÃ¢â?¬â?¢s clinical pipeline includes both wholly owned and partnered programs being developed for the potential treatment of diseases including AL amyloidosis, ATTR amyloidosis, AlzheimerÃ¢â?¬â?¢s disease, ParkinsonÃ¢â?¬â?¢s disease and other neurodegenerative diseases. The company was founded in December 1969 and is headquartered in Dublin, Ireland.